USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis PressReach · Dec 8, 2022
Trevena Announces Poster Presentations of TRV045 Nonclinical Epilepsy Data, and OLINVYK Clinical Neurocognitive and GI Data, at Recent Medical Meetings PressReach · Dec 8, 2022
BD Named in top 25% of Newsweek's 2023 List of America's Most Responsible Companies PressReach · Dec 8, 2022
Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer PressReach · Dec 8, 2022
AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress PressReach · Dec 6, 2022